Fact CheckerSign in

NCT07350954Recruiting

Acceptability and Feasibility of a Brief Paranoia Intervention.

Assessing the Acceptability and Feasibility of TRUST, a Brief Intervention for Paranoia in Adolescents.

Source: ClinicalTrials.gov · Last updated 20 Jan 2026

Brief summary (registry, in English)

The goal of this feasibility and acceptability trial is to test whether a new brief talking therapy can be successfully provided to and is suitable for adolescents (16-18) who are seeking help from Child and Adolescent Mental Health Services (CAMHS). The main research question for the current study is: Is it feasible and acceptable to offer a brief values-based (helping young people identify what matters most to them) and imagery (using imagination to visualise positive experiences) intervention for adolescents experiencing paranoia in CAMHS? It also aims to identify preliminary clinical outcomes, particularly changes in paranoia severity as measured by the Revised Green et al., Paranoid Thoughts Scale (R-GPTS). Participants will complete an eligibility assessment and those eligible will be offered a six-session intervention. Assessment measures will be completed before, during and after the intervention.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
8 (estimated)
First submitted
8 Dec 2025
Start date
24 Oct 2025
Primary completion date
Apr 2026
Lead sponsor
Lucy Jonas
NCT number
NCT07350954

What you commit to

  • Study type: Interventional
  • Planned participants: 8
  • From 24 Oct 2025 to the primary completion date, Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Concurrent participation in another psychological therapy

Other illness

  • The presence of a developmental disability or cognitive impairment that would interfere with participation.

Other

  • Severe comorbid diagnoses apparent at the initial assessment (e.g., a primary alcohol or substance dependence issue measured using standardised assessments)
  • High levels of current risk (e.g., significant and immediate concerns about the young person's safety, such as suicidal intent).

Who the study is looking for

  • Aged 16-18
  • Seeking help from a Child and Adolescent Mental Health Service (CAMHS)
  • A score ≥ 11 on the R-GPTS (Scale B)
  • Sufficient understanding of English
  • Capacity to consent, as assessed during the initial interview
  • Wanting support with paranoia
  • Low- moderate mental health risks (emotional difficulties that impact functioning, but no immediate risk to safety e.g., no suicidal intent).

Age in the registry: 16 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Westminster's Child and Adolescent Mental Health Service
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.